The NLRP3 inflammasome: an emerging therapeutic target for chronic pain

Volume: 18, Issue: 1
Published: Mar 30, 2021
Abstract
Chronic pain affects the life quality of the suffering patients and posts heavy problems to the health care system. Conventional medications are usually insufficient for chronic pain management and oftentimes results in many adverse effects. The NLRP3 inflammasome controls the processing of proinflammatory cytokine interleukin 1β (IL-1β) and is implicated in a variety of disease conditions. Recently, growing number of evidence suggests that...
Paper Details
Title
The NLRP3 inflammasome: an emerging therapeutic target for chronic pain
Published Date
Mar 30, 2021
Volume
18
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.